These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27106505)

  • 1. Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients.
    Esteghamati A; Momeni A; Abdollahi A; Khandan A; Afarideh M; Noshad S; Nakhjavani M
    Ann Endocrinol (Paris); 2016 Oct; 77(5):586-592. PubMed ID: 27106505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serum fibroblast growth factor 21 is correlated with retinopathy in patients with type 2 diabetes mellitus.
    Heidari Z; Hasanpour M
    Diabetes Metab Syndr; 2021; 15(6):102296. PubMed ID: 34592531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum fibroblast growth factor 21 levels are correlated with the severity of diabetic retinopathy.
    Lin Y; Xiao YC; Zhu H; Xu QY; Qi L; Wang YB; Li XJ; Zheng ML; Zhong RS; Zhang Y; Xu XD; Wu BL; Xu ZM; Lu XH
    J Diabetes Res; 2014; 2014():929756. PubMed ID: 24895642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The U-shaped relationship between fibroblast growth factor 21 and microvascular complication in type 2 diabetes mellitus.
    Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
    J Diabetes Complications; 2017 Jan; 31(1):134-140. PubMed ID: 27839924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between serum fibroblast growth factor 21 level and sight-threatening diabetic retinopathy in Chinese patients with type 2 diabetes.
    Jin S; Xia N; Han L
    BMJ Open Diabetes Res Care; 2021 Mar; 9(1):. PubMed ID: 33789910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
    Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between serum levels of fibroblast growth factor 21 and diabetic retinopathy.
    Mousavi Z; Bonakdaran S; Sahebkar A; Yaghoubi G; Yaghoubi MA; Davoudian N; Mohebbi M
    EXCLI J; 2017; 16():1249-1256. PubMed ID: 29285020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus.
    Taniguchi H; Nirengi S; Ishihara K; Sakane N
    PLoS One; 2022; 17(2):e0263774. PubMed ID: 35192641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.
    Lee CH; Hui EY; Woo YC; Yeung CY; Chow WS; Yuen MM; Fong CH; Xu A; Lam KS
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1368-75. PubMed ID: 25625802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes.
    Hong ES; Lim C; Choi HY; Lee YK; Ku EJ; Moon JH; Park KS; Jang HC; Choi SH
    BMJ Open Diabetes Res Care; 2019; 7(1):e000776. PubMed ID: 31798902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of fibroblast growth factor 21 in early-stage diabetic kidney disease.
    Esteghamati A; Khandan A; Momeni A; Behdadnia A; Ghajar A; Nikdad MS; Noshad S; Nakhjavani M; Afarideh M
    Ir J Med Sci; 2017 Aug; 186(3):785-794. PubMed ID: 28181108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques.
    An SY; Lee MS; Yi SA; Ha ES; Han SJ; Kim HJ; Kim DJ; Lee KW
    Diabetes Res Clin Pract; 2012 May; 96(2):196-203. PubMed ID: 22293928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes.
    Reinehr T; Karges B; Meissner T; Wiegand S; Fritsch M; Holl RW; Woelfle J
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3004-10. PubMed ID: 26052728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes.
    Lu J; Yu H; Mo Y; Ma X; Hao Y; Lu W; Li H; Bao Y; Zhou J; Jia W
    PLoS One; 2015; 10(11):e0142207. PubMed ID: 26540514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients.
    Zhang X; Hu Y; Zeng H; Li L; Zhao J; Zhao J; Liu F; Bao Y; Jia W
    Cardiovasc Diabetol; 2015 Mar; 14():32. PubMed ID: 25850006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.
    Mraz M; Bartlova M; Lacinova Z; Michalsky D; Kasalicky M; Haluzikova D; Matoulek M; Dostalova I; Humenanska V; Haluzik M
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):369-75. PubMed ID: 19702724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased circulating FGF21 level predicts the burden of metabolic demands and risk of vascular diseases in adults with type 2 diabetes.
    Liu Z; Peng Y; Li S; Lin Y; Huang Y; Chen W; Bao C; Zhou Z; Lin Z; Chen L
    BMC Endocr Disord; 2023 Dec; 23(1):272. PubMed ID: 38057786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus.
    Lee CH; Woo YC; Chow WS; Cheung CYY; Fong CHY; Yuen MMA; Xu A; Tse HF; Lam KSL
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF21 and glycemic control in patients with T1D.
    Rosell Rask S; Krarup Hansen T; Bjerre M
    Endocrine; 2019 Sep; 65(3):550-557. PubMed ID: 31372821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes.
    Xiao Y; Xu A; Law LS; Chen C; Li H; Li X; Yang L; Liu S; Zhou Z; Lam KS
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E54-8. PubMed ID: 22013098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.